Clinical Trials in Pittsburgh

Showing 4721-4740 of 16,007 trials

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

NCT03956680

The main purpose of this study is to characterize the safety, tolerability, dose limiting toxicities, best route of administration, maximum tolerated dose, maximum administered dose, or alternative dose of BMS-986301 alone or in combination with nivolumab and ipilimumab in participants with cancers that have failed to respond to T cell checkpoint inhibiting antibodies.

Advanced Solid Cancers

Bristol-Myers Squibb54 participantsStarted Mar 2019

Chicago, Illinois, United States • St Louis, Missouri, United States • Pittsburgh, Pennsylvania, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

NCT02043678

To determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer which has spread to the bone, such as painful fractures or bone pain which needs to be treated with an X-ray machine.

Prostatic Neoplasms

Bayer806 participantsStarted Mar 2014

Anchorage, Alaska, United States • Tucson, Arizona, United States • Oceanside, California, United States +160 more locations

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Find Trials by Condition in Pittsburgh

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

Detecting Change in Muscle Parameters, Pain, and Function With NMES for TTA

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Neuroblastoma Precision Trial

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Communication During Hospitalization About Resuscitation Trial

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis